Opioids Global Market Report 2024

Description

“Opioids Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on opioids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for opioids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The opioids market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: Methadone; Codeine; Fentanyl; Oxycodone; Morphine; Hydrocodone; Other Product Types
2) By Receptor Binding: Strong Agonist; Mild To Moderate Agonist
3) By Basis Of Indication: Inflammatory Condition; Musculoskeletal Pain; Neuropathic Pain; Cancer Pain
4) By Distribution Channel: Hospital; Retail Pharmacies; Online Pharmacies
5) By Application: Pain Management; Cough Treatment; Diarrhea Treatment
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; AbbVie Inc.; Sanofi S.A; AstraZeneca Plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Opioids refer to a class of potent medications derived from the opium poppy plant or synthesized in laboratories. They exert their effects on the nervous system to alleviate pain. Opioids are highly effective in managing moderate to severe pain, including post-surgery pain, cancer-related pain, and chronic pain disorders. They are also used to address issues such as coughing and diarrhea.

The primary types of opioid products include methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone, and others. Methadone is a medication utilized in opioid addiction treatment programs to help individuals reduce or cease their use of heroin or other opioids. Opioids work by binding to various receptors, including strong agonists and mild to moderate agonists, in the nervous system. They are administered for a range of symptoms and indications, including inflammatory conditions, musculoskeletal pain, neuropathic pain, and cancer pain. Opioid medications are available in hospitals, retail pharmacies, and online pharmacies and are used in various medical applications, such as pain management, cough treatment, and diarrhea treatment.

The opioids market research report is one of a series of new reports from The Business Research Company that provides opioids market statistics, including the opioids industry's global market size, regional shares, competitors with an opioids market share, detailed opioids market segments, market trends and opportunities and any further data you may need to thrive in the opioid industry. This opioid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The opioids market size has grown steadily in recent years. It will grow from $22.77 billion in 2023 to $23.54 billion in 2024 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to pain management, surgical procedures, palliative care, regulatory environment.

The opioids market size is expected to see steady growth in the next few years. It will grow to $26.51 billion in 2028 at a compound annual growth rate (CAGR) of 3.0%. The growth in the forecast period can be attributed to non-cancer pain indications, regulatory changes, telemedicine and remote prescribing, chronic pain management. Major trends in the forecast period include opioid-sparing strategies, medication-assisted treatment (mat), risk mitigation, public health initiatives.

The escalating number of surgical procedures is poised to act as a driving force behind the expansion of the opioids market in the foreseeable future. Surgical procedures encompass a spectrum of medical interventions involving incisions made with specialized tools, typically performed in controlled environments such as operating rooms, often necessitating the use of anesthesia or respiratory support. Opioids play a vital role during surgical procedures for managing pain and can serve as adjuncts to anesthesia or even as primary anesthetic agents. For instance, in August 2023, data from the Organization for Economic Co-operation and Development, an intergovernmental organization headquartered in France, revealed that the Czech Republic witnessed an 8.4% increase in the total number of cataract surgical procedures, rising from 131,612 procedures in 2021 to 142,670 in 2022. Furthermore, the total count of laparoscopic repairs for inguinal hernia surgical procedures in Turkey surged by 35.2%, reaching 25,348 in 2022 from 18,739 in 2021. Hence, the upswing in surgical procedures is poised to propel the opioids market.

The mounting prevalence of chronic diseases is expected to be a pivotal driver for the burgeoning opioids market. Chronic diseases, also recognized as non-communicable diseases (NCDs), encompass a spectrum of persistent medical conditions characterized by gradual progression and prolonged duration. These ailments typically endure over an extended period, often persisting for years or even throughout a lifetime, without spontaneous resolution. The burgeoning prevalence of chronic diseases constitutes a central element of the opioids market. With a growing population afflicted by chronic ailments and enduring chronic pain, the demand for opioids is on the rise. Opioid utilization within the context of chronic disease management is a dynamic and evolving facet of healthcare, renowned for its effectiveness in pain relief. For example, according to the World Health Organization, an agency specialized in health matters and headquartered in Switzerland, chronic diseases contribute to a substantial global burden, causing 41 million deaths each year, accounting for 74% of all fatalities. Among these chronic diseases, cardiovascular diseases cause 17.9 million deaths, cancer leads to 9.3 million deaths, chronic respiratory diseases result in 4.1 million deaths, and diabetes is responsible for 2.0 million deaths. Consequently, the escalating prevalence of chronic diseases is fostering the growth of the opioids market.

The growth of the opioids market is impeded by regulatory restrictions during the forecast period. Regulatory restrictions are primarily established to curtail the use of opioids for various pivotal reasons, including reducing the supply of opioids, increasing prices, lowering demand, and mitigating the elevated risks associated with diversion and misuse. For example, in 2021, as reported by Science Direct, a bibliographic database encompassing scientific and medical literature, stringent regulations imposed severe limitations on the extended usage of opioids among patients not afflicted with cancer-related pain. Only a minority of individuals prescribed opioids like fentanyl (approximately 20%) and morphine (less than 2%) were authorized to receive prescriptions allowing them to possess a supply of these medications for more than 28 days annually. Consequently, regulatory constraints are acting as a hindrance to the growth of the opioids market.

Prominent companies operating in the opioid market are dedicated to pioneering advanced pharmaceutical solutions to strengthen their market position. The development of novel medications holds the potential to treat diseases, elevate healthcare standards, and contribute to scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a U.S.-based provider of solutions for opioid addiction treatment, announced the U.S. Food and Drug Administration's approval of Brixadi (buprenorphine) extended-release subcutaneous injection for the management of moderate to severe opioid use disorder (OUD). This marks the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, employing the innovative FluidCrystal Injection Depot Technology. The prescription recommendations allow patients receiving oral buprenorphine-containing medications to transition to equivalent dosages if followed.

In March 2023, Indivior PLC, a U.S.-based specialty pharmaceuticals company, acquired Opiant Pharmaceuticals Inc. for $145 million. This acquisition empowers Indivior to establish a comprehensive and relevant treatment platform to address the ongoing opioid and overdose crisis in the United States. It bolsters Indivior's addiction treatment and scientific portfolio by incorporating Opiant's late-stage assets, particularly OPNT003. Opiant Pharmaceuticals Inc. is a U.S.-based developer of therapies designed to combat opioid drug overdose and addiction.

Major players in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

North America was the largest region in the opioids market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the opioids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The opioids market consists of sales of oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12367

1. Executive Summary

2. Opioids Market Characteristics

3. Opioids Market Trends And Strategies

4. Opioids Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Opioids Market Size and Growth

5.1. Global Opioids Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Opioids Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Opioids Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Opioids Market Segmentation

6.1. Global Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Methadone
Codeine
Fentanyl
Oxycodone
Morphine
Hydrocodone
Other Product Types
6.2. Global Opioids Market, Segmentation By Receptor Binding, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Strong Agonist
Mild To Moderate Agonist
6.3. Global Opioids Market, Segmentation By Basis Of Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Inflammatory Condition
Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
6.4. Global Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital
Retail Pharmacies
Online Pharmacies
6.5. Global Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pain Management
Cough Treatment
Diarrhea Treatment

7. Opioids Market Regional And Country Analysis

7.1. Global Opioids Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Opioids Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Opioids Market

8.1. Asia-Pacific Opioids Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Opioids Market

9.1. China Opioids Market Overview
9.2. China Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Opioids Market

10.1. India Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Opioids Market

11.1. Japan Opioids Market Overview
11.2. Japan Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Opioids Market

12.1. Australia Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Opioids Market

13.1. Indonesia Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Opioids Market

14.1. South Korea Opioids Market Overview
14.2. South Korea Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Opioids Market

15.1. Western Europe Opioids Market Overview
15.2. Western Europe Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Opioids Market

16.1. UK Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Opioids Market

17.1. Germany Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Opioids Market

18.1. France Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Opioids Market

19.1. Italy Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Opioids Market

20.1. Spain Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Opioids Market

21.1. Eastern Europe Opioids Market Overview
21.2. Eastern Europe Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Opioids Market

22.1. Russia Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Opioids Market

23.1. North America Opioids Market Overview
23.2. North America Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Opioids Market

24.1. USA Opioids Market Overview
24.2. USA Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Opioids Market

25.1. Canada Opioids Market Overview
25.2. Canada Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Opioids Market

26.1. South America Opioids Market Overview
26.2. South America Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Opioids Market

27.1. Brazil Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Opioids Market

28.1. Middle East Opioids Market Overview
28.2. Middle East Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Opioids Market

29.1. Africa Opioids Market Overview
29.2. Africa Opioids Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Opioids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Opioids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Opioids Market Competitive Landscape And Company Profiles

30.1. Opioids Market Competitive Landscape
30.2. Opioids Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi S.A
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AstraZeneca Plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Opioids Market Other Major And Innovative Companies

31.1. Viatris Inc.
31.2. Teva Pharmaceutical Industries Limited
31.3. Sandoz Inc.
31.4. Sun Pharmaceutical Industries Limited
31.5. Aurobindo Pharma Limited
31.6. Purdue Pharma L.P.
31.7. Dr. Reddy's Laboratories Ltd.
31.8. Hikma Pharmaceuticals plc
31.9. Endo Pharmaceuticals Inc.
31.10. Amneal Pharmaceuticals Inc.
31.11. Mallinckrodt Pharmaceuticals plc
31.12. Alkermes plc
31.13. Lannett Co Inc.
31.14. Par Pharmaceutical Inc.
31.15. Mayne Pharma Group Ltd.

32. Global Opioids Market Competitive Benchmarking

33. Global Opioids Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Opioids Market

35. Opioids Market Future Outlook and Potential Analysis

35.1 Opioids Market In 2028 - Countries Offering Most New Opportunities
35.2 Opioids Market In 2028 - Segments Offering Most New Opportunities
35.3 Opioids Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer